{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/immunizations-travel/management/tick-borne-encephalitis/","result":{"pageContext":{"chapter":{"id":"85c90e1f-26f4-503b-b0b0-7c5a38930086","slug":"tick-borne-encephalitis","fullItemName":"Scenario: Tick-borne encephalitis","depth":2,"htmlHeader":"<!-- begin field fb17a975-78a1-4277-a8f1-342741756b42 --><h2>Scenario: Tick-borne encephalitis</h2><!-- end field fb17a975-78a1-4277-a8f1-342741756b42 -->","summary":"Covers advice for people travelling to areas endemic with tick-borne encephalitis.","htmlStringContent":"<!-- begin item ea09aeed-c4f0-46a0-8d70-513c2b98fe89 --><!-- begin field a2ce15be-60b1-4fc2-b4af-acd900ab5249 --><p>From age 12 months onwards.</p><!-- end field a2ce15be-60b1-4fc2-b4af-acd900ab5249 --><!-- end item ea09aeed-c4f0-46a0-8d70-513c2b98fe89 -->","topic":{"id":"8f89ca7f-a4f5-5e7d-80c8-de5db64ca7f0","topicId":"16d61716-d647-48bc-827b-b2b115ecd0fb","topicName":"Immunizations - travel","slug":"immunizations-travel","lastRevised":"Last revised in January 2021","chapters":[{"id":"25b90177-7e96-59db-b325-abc5f51c8721","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"bc7c22b0-dd64-50ad-8110-1fff4c8d6736","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"50f55046-7ca2-567f-94df-9c58f13770a5","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"2221cdd9-5576-5b5b-ad29-eff077930653","slug":"changes","fullItemName":"Changes"},{"id":"c755b06c-072d-5e60-be73-155dd664c37d","slug":"update","fullItemName":"Update"}]},{"id":"f5871d9a-dff3-59ce-a611-88d2ec41f5ce","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"513a86a0-e305-5e59-bd0d-1fb74a6e8689","slug":"goals","fullItemName":"Goals"},{"id":"87ea4699-bd41-5aeb-aa62-eac1fb591c4d","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c8b054a0-ee87-5f9e-aa8f-c1fdf8442a29","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"a8eb4582-f05d-5af5-ae78-497260724f93","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"6f29b0b8-4b10-5e26-9ece-4cec050b1eb0","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"79cb1d1a-ebd1-58c6-9bc5-2bfd006c22c1","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"8d3187f5-2a99-5108-a7c9-dd601d729381","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"055aad08-f5af-5b2f-bda0-a35213a2a071","slug":"travel-vaccinations","fullItemName":"Travel vaccinations"},{"id":"c8d1352b-616b-5dff-9517-ea235b83e9d9","slug":"diseases-commonly-requiring-vaccination","fullItemName":"Diseases commonly requiring vaccination"},{"id":"041fa115-033d-5525-91ce-c43dbf593bd4","slug":"other-diseases-requiring-vaccination","fullItemName":"Other diseases requiring vaccination"},{"id":"1fe14ee1-a79f-565a-9380-ae3be597d7d5","slug":"where-these-diseases-are-prevalent","fullItemName":"Where these diseases are prevalent"},{"id":"68e09f74-2282-532f-ae34-064998823fc1","slug":"payment-for-travel-vaccinations","fullItemName":"Payment for travel vaccinations"}]},{"id":"0e45089d-2317-5ec5-8c73-f0709c003c48","fullItemName":"Management","slug":"management","subChapters":[{"id":"9c16c0cb-4e78-523d-914f-e884aea62565","slug":"initial-assessment-advice","fullItemName":"Scenario: Initial assessment and advice"},{"id":"f911dc04-ffd0-5a41-a3cb-b724797a7589","slug":"cholera","fullItemName":"Scenario: Cholera"},{"id":"422ff6d3-5810-5d3c-93b3-c5a67faaa0e1","slug":"hepatitis-a","fullItemName":"Scenario: Hepatitis A"},{"id":"01d49a70-70f4-547a-a551-ab524f99c944","slug":"hepatitis-b","fullItemName":"Scenario: Hepatitis B"},{"id":"5c77503c-2f59-5696-908b-125fe0e8e41c","slug":"japanese-encephalitis","fullItemName":"Scenario: Japanese encephalitis"},{"id":"8cb4ca86-fe31-5603-a75e-84413c2b5346","slug":"meningococcal-meningitis","fullItemName":"Scenario: Meningococcal meningitis"},{"id":"0e84be27-375b-55f5-9f51-d0e4cc422b58","slug":"poliomyelitis","fullItemName":"Scenario: Poliomyelitis"},{"id":"37a96f8b-4158-5e62-8e3d-6cedae506976","slug":"rabies","fullItemName":"Scenario: Rabies"},{"id":"8c237a0e-a760-55b2-b7b0-5383b7653be3","slug":"tetanus","fullItemName":"Scenario: Tetanus"},{"id":"85c90e1f-26f4-503b-b0b0-7c5a38930086","slug":"tick-borne-encephalitis","fullItemName":"Scenario: Tick-borne encephalitis"},{"id":"4e817d26-15f3-5ff7-a672-11caa36ffb68","slug":"typhoid-fever","fullItemName":"Scenario: Typhoid fever"},{"id":"5ec20606-2af2-556b-98a6-d8673a21a09d","slug":"yellow-fever","fullItemName":"Scenario: Yellow fever"},{"id":"e0a021ac-7c76-551a-97af-25341142d54f","slug":"hajj-umrah-pilgrims","fullItemName":"Scenario: Hajj and Umrah pilgrims"},{"id":"087d9fbb-1ec6-5f08-8e76-5df3a4a0b863","slug":"rapid-vaccination-courses-vaccination-at-short-notice","fullItemName":"Scenario: Rapid vaccination courses and vaccination at short notice"}]},{"id":"79dee816-dbdb-5426-8db3-2f095eedbff3","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"f1e9d43f-6815-516a-8511-3fd34a06525d","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a69fb594-d4b4-56e6-b46a-6283ead93e30","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"52eea726-d50b-5e4f-a22c-764c1961119d","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b2033c1b-25a2-5a58-b99e-00baf9b02a96","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"6df4842b-8812-534e-975d-52d29f3a8ee4","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"81e42472-4b49-5390-8179-0d131f547700","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"86482706-09b2-5113-bd4e-261c392f6483","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"0e45089d-2317-5ec5-8c73-f0709c003c48","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"1cc2e8fc-0287-509d-9dd8-05ce33b72336","slug":"indications-for-vaccine","fullItemName":"Indications for vaccine","depth":3,"htmlHeader":"<!-- begin field 117fd403-6ad5-4a4b-92b2-5fa146bfbeb6 --><h3>Indications for vaccine</h3><!-- end field 117fd403-6ad5-4a4b-92b2-5fa146bfbeb6 -->","summary":null,"htmlStringContent":"<!-- begin item 03c3c053-cac1-42cd-bc41-29d7893b9f66 --><!-- begin field af8fa218-08ce-4034-96cc-ca18279731d7 --><ul><li><strong>Tick-borne encephalitis vaccination is advised for people travelling to or going to reside in endemic areas. </strong>Vaccination is particularly important for people:<ul><li>Travelling to warm, forested parts of the endemic areas, particularly during the spring and summer.</li><li>Hiking, camping, hunting, or carrying out fieldwork.</li><li>Working in forestry, woodcutting, or the military.</li></ul></li><li>Note: The person should be advised that they can further decrease their risk of contracting tick-borne encephalitis by covering arms, legs, and ankles when in high-risk areas, and using insect repellents on socks and outer clothes. Any ticks attaching to the skin should be removed completely as soon as possible. Evidence suggests that the best method is slow, straight removal with tweezers.</li></ul><!-- end field af8fa218-08ce-4034-96cc-ca18279731d7 --><!-- end item 03c3c053-cac1-42cd-bc41-29d7893b9f66 -->","subChapters":[{"id":"b1baf2c7-2573-5f9e-ae85-dbf7a25a936c","slug":"basis-for-recommendation-820","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 8d7a58c7-0786-4a3d-b32d-f847a0ac010f --><h4>Basis for recommendation</h4><!-- end field 8d7a58c7-0786-4a3d-b32d-f847a0ac010f -->","summary":null,"htmlStringContent":"<!-- begin item 820b3e8a-518c-47ce-88f2-4c5681b08638 --><!-- begin field dfbe859f-0ea7-438d-9e1a-8745d1a931a6 --><p>The recommendations on indications for tick-borne encephalitis vaccination are based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 31: Tick-borne encephalitis </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013d</a>].</p><!-- end field dfbe859f-0ea7-438d-9e1a-8745d1a931a6 --><!-- end item 820b3e8a-518c-47ce-88f2-4c5681b08638 -->","subChapters":[]}]},{"id":"9615d9f9-f3f1-5bdb-8e0e-3d540d167376","slug":"available-vaccines-vaccination-schedules","fullItemName":"Available vaccines and vaccination schedules","depth":3,"htmlHeader":"<!-- begin field 028445c5-cbfa-4803-ad47-314158056a54 --><h3>Available vaccines and vaccination schedules</h3><!-- end field 028445c5-cbfa-4803-ad47-314158056a54 -->","summary":null,"htmlStringContent":"<!-- begin item 84d8ac76-2d74-4ccd-9165-ab63cd625b3a --><!-- begin field 4e1682dc-57f8-4e6f-a10d-b408ae6a7535 --><ul><li><strong>Ticovac<sup>® </sup>(indicated for people from 16 years of age) and Ticovac Junior<sup>®</sup> (lower dose indicated in children and young people below 16 years of age) is the only available<sup> </sup>vaccine for tick-borne encephalitis in the UK.</strong></li><li>The primary course consists of three doses: the first on day 0, the second 1–3 months later, and the third 5–12 months after the second dose. However, for rapid short-term protection of children and adults, the second dose may be given 2 weeks after the first dose and offers at least 90% protection.</li><li>Boosters are recommended every 3 years starting after an initial three-dose schedule if the person remains at risk.</li></ul><!-- end field 4e1682dc-57f8-4e6f-a10d-b408ae6a7535 --><!-- end item 84d8ac76-2d74-4ccd-9165-ab63cd625b3a -->","subChapters":[{"id":"7c955247-4a96-5e5d-b72d-74ad13fb1f51","slug":"basis-for-recommendation-831","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 6c8726fe-9e26-45ee-9d09-da72e9133ecb --><h4>Basis for recommendation</h4><!-- end field 6c8726fe-9e26-45ee-9d09-da72e9133ecb -->","summary":null,"htmlStringContent":"<!-- begin item 83163938-6771-4d54-83f4-77a72d71d5e8 --><!-- begin field f3354c78-8719-4380-bcb9-16955d50119a --><p>The information on available types of tick-borne encephalitis vaccine and immunization schedule is based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 31: Tick-borne encephalitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013d</a>].</p><!-- end field f3354c78-8719-4380-bcb9-16955d50119a --><!-- end item 83163938-6771-4d54-83f4-77a72d71d5e8 -->","subChapters":[]}]},{"id":"f77d36e4-84ec-5415-bb41-119ba8ab9c51","slug":"contraindications-to-vaccine","fullItemName":"Contraindications to vaccine","depth":3,"htmlHeader":"<!-- begin field 98f2f042-aaf1-4d4d-b615-0f18ef51ac59 --><h3>Contraindications to vaccine</h3><!-- end field 98f2f042-aaf1-4d4d-b615-0f18ef51ac59 -->","summary":null,"htmlStringContent":"<!-- begin item a19ae8a8-f89f-4a33-b088-c9430b88d62d --><!-- begin field 9b0cd085-1bcc-4340-b47d-748b7883a44a --><ul><li><strong>Tick-borne encephalitis vaccine should not be given to people who have had:</strong><ul><li>A confirmed anaphylactic reaction following a previous dose.</li><li>A confirmed anaphylactic reaction to one of the vaccine components.</li><li>A confirmed anaphylactic reaction to egg ingestion.</li></ul></li><li><strong>Postpone tick-borne encephalitis vaccination if the person has a current severe febrile illness.</strong><ul><li>Minor illness without fever or systemic upset is <em>not</em> a valid reason to postpone immunization.</li></ul></li><li><strong>Tick-borne encephalitis vaccine may be given to pregnant women when protection is required without delay.</strong> There is no evidence of risk from vaccinating pregnant women or those who are breastfeeding with inactivated virus, bacterial vaccines, or toxoids.</li></ul><!-- end field 9b0cd085-1bcc-4340-b47d-748b7883a44a --><!-- end item a19ae8a8-f89f-4a33-b088-c9430b88d62d -->","subChapters":[{"id":"4d8bc98a-a410-5f73-b735-a6db854c1643","slug":"basis-for-recommendation-25b","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 14c7b9ae-ca08-40ce-b2fb-3f7e8f54f93f --><h4>Basis for recommendation</h4><!-- end field 14c7b9ae-ca08-40ce-b2fb-3f7e8f54f93f -->","summary":null,"htmlStringContent":"<!-- begin item 25b079b4-85bb-41d2-b34b-79058a9be729 --><!-- begin field 00bb7c3b-4c83-495a-8bd2-da117249167c --><p>The recommendations on contraindications to tick-borne encephalitis vaccination are based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 31: Tick-borne encephalitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013d</a>] and <em>Chapter 6: Contraindications and special considerations</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2017a</a>].</p><!-- end field 00bb7c3b-4c83-495a-8bd2-da117249167c --><!-- end item 25b079b4-85bb-41d2-b34b-79058a9be729 -->","subChapters":[]}]},{"id":"4685cfc0-d5bb-5d86-bcd4-fcb452d64aca","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 61e69379-9283-4f5e-a8a1-9d8cd4f9cba6 --><h3>Adverse effects</h3><!-- end field 61e69379-9283-4f5e-a8a1-9d8cd4f9cba6 -->","summary":null,"htmlStringContent":"<!-- begin item 8551c654-f0b6-466e-a6a1-8606fddb8b83 --><!-- begin field 75a24db1-99fb-40c3-8f00-e1bbac5c2532 --><ul><li>Reported reactions to tick-borne encephalitis vaccine are rare. Local reactions such as swelling, pain, and redness at the injection site may occur.</li><li>Pyrexia, particularly after the first dose, can occur in children and adults, usually within 12 hours of immunization, settling within 24–48 hours.</li><li>Febrile convulsions have rarely occurred.</li><li>Guillain–Barré syndrome is rare adverse effect of TicoVac<sup>®</sup>.</li></ul><!-- end field 75a24db1-99fb-40c3-8f00-e1bbac5c2532 --><!-- end item 8551c654-f0b6-466e-a6a1-8606fddb8b83 -->","subChapters":[{"id":"fdc67fa2-f0b7-53ab-bb69-ddb86f5be81a","slug":"basis-for-recommendation-514","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 8885c565-9a80-4365-a3d5-80f2df4e0357 --><h4>Basis for recommendation</h4><!-- end field 8885c565-9a80-4365-a3d5-80f2df4e0357 -->","summary":null,"htmlStringContent":"<!-- begin item 5143715b-9d24-4bf1-ac8c-9970816e168a --><!-- begin field fbb69567-43b7-427a-a595-d7cbce21d373 --><p>The information on adverse effects of tick-borne encephalitis vaccination is based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 31: Tick-borne encephalitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013d</a>] and from information provided by the manufacturer [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">ABPI, 2018</a>].</p><!-- end field fbb69567-43b7-427a-a595-d7cbce21d373 --><!-- end item 5143715b-9d24-4bf1-ac8c-9970816e168a -->","subChapters":[]}]},{"id":"9fd12a2c-05c8-5d82-a130-0a2b8f852bd1","slug":"how-to-administer-tick-borne-encephalitis-vaccine","fullItemName":"How to administer tick-borne encephalitis vaccine","depth":3,"htmlHeader":"<!-- begin field 2644fdc1-49b0-4b29-9ef5-c31fd0ba6836 --><h3>How to administer tick-borne encephalitis vaccine</h3><!-- end field 2644fdc1-49b0-4b29-9ef5-c31fd0ba6836 -->","summary":null,"htmlStringContent":"<!-- begin item 1757409d-36a1-4177-9dad-bcd572856445 --><!-- begin field 92b5f86c-42a3-442f-923d-bbe16edac6d7 --><ul><li><strong>Obtain written or verbal consent at the time of vaccination for people aged over 16 years.</strong><strong> For younger people it is usual to get consent from a person with parental responsibility.</strong><ul><li>Adults over 18 years of age are presumed to be competent to consent to treatment provided they can comprehend and retain the information they are given, and they can consider the facts and make an informed decision.</li></ul></li><li><strong>Ensure that:</strong> <ul><li>There are no <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-travel/management/tick-borne-encephalitis/#contraindications-to-vaccine\">contraindications</a> to the vaccine.</li><li>The person, parent, or carer has been fully informed about the vaccine and the vaccination procedure.</li><li>Possible <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-travel/management/tick-borne-encephalitis/#adverse-effects\">adverse reactions</a> have been discussed and the person, parent, or carer is aware of how to manage them. </li><li>The vaccine is correct, has been stored appropriately, and has not expired. </li></ul><ul><li>The vaccination site has been washed with soap and water if it is visibly dirty. </li></ul></li><li><strong>Tick-borne encephalitis vaccine is usually given by intramuscular (IM) injection,</strong> into the upper arm in children over 1 year of age, and adults. However, if the person has a bleeding disorder, the vaccine should be given by deep subcutaneous (SC) injection to reduce the risk of bleeding. </li><li><strong>Tick-borne encephalitis vaccine can be given at the same time as other vaccines.</strong> If an additional vaccine is required on the same day, use separate limbs if possible, or inject at sites at least 2.5 cm apart. </li><li><strong>Record the date of administration, vaccine and product name, batch number, expiry date, dose administered, and site of administration for each vaccine.</strong> </li><li><strong>Observe the person after vaccination to detect immediate adverse reactions.</strong> Ensure any bleeding has stopped and check for any symptoms of anaphylaxis before they leave.<ul><li>Anaphylaxis is extremely rare, and usually becomes apparent within minutes. By the time the site has been checked for bleeding and documentation has been completed, most reactions will have become apparent. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a>.</li></ul></li></ul><!-- end field 92b5f86c-42a3-442f-923d-bbe16edac6d7 --><!-- end item 1757409d-36a1-4177-9dad-bcd572856445 -->","subChapters":[{"id":"35cea5d5-0f9e-5b46-87fd-88acb62aff43","slug":"basis-for-recommendation-206","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field f0523a14-7084-48a4-8947-633c98633674 --><h4>Basis for recommendation</h4><!-- end field f0523a14-7084-48a4-8947-633c98633674 -->","summary":null,"htmlStringContent":"<!-- begin item 206e5cfb-898c-4d20-972f-bac488bb091d --><!-- begin field 1111cd89-a648-4f9d-9564-a1fd1499a3a1 --><p>The recommendations on administering tick-borne encephalitis vaccine are based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 31: Tick-borne encephalitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013d</a>], <em>Chapter 2: Consent</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013e</a>], <em>Chapter 4: Immunisation procedures</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013f</a>], and <em>Chapter 8: Vaccine safety and adverse effects</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013g</a>], and are also pragmatic, based on what CKS considers to be good clinical practice.</p><h5>Obtaining consent</h5><ul><li>Consent for immunizations does not legally have to be in writing, but must be given voluntarily by a fully informed person who is able to make and communicate their decision. For children not competent to give or withhold consent, a person with parental responsibility can provide this [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013e</a>].</li></ul><h5>Site of administration</h5><div><ul><li>In people over the age of 1 year, vaccines are routinely given into the deltoid muscle as it is convenient, providing easy access, and it reduces the risk of localized reactions, which are common when vaccines are given subcutaneously.</li><li>The gluteal muscle should be avoided. The needle may not penetrate through adipose tissue into the muscle, and this may cause a poor immunological response to the vaccine. In addition, there is a risk of damage to underlying structures such as the sciatic nerve [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013f</a>].</li></ul></div><!-- end field 1111cd89-a648-4f9d-9564-a1fd1499a3a1 --><!-- end item 206e5cfb-898c-4d20-972f-bac488bb091d -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}